Table 4 Sensitivity analysis for 269 participants with non-pathology-based diagnoses or digestive diseases other than cholangiocarcinoma

269

1.34 (0.81–2.21)

1.38 (0.90–2.12)

2.52 (1.58–4.00)

1.39 (1.00–1.93)

243

1.26 (0.79–2.00)

1.39 (0.93–2.04)

2.53 (1.65–2.88)

1.40 (1.03–1.90)

215

1.39 (0.90–2.14)

1.29 (0.88–1.87)

2.52 (1.70–3.76)

1.41 (1.06–1.88)

188

1.43 (0.97–2.10)

0.99 (0.70–1.40)

1.91 (1.30–2.82)

1.18 (0.91–1.54)

160

1.51 (1.05–2.18)

0.96 (0.69–1.33)

1.97 (1.37–2.84)

1.21 (0.94–1.55)

135

1.42 (1.00–2.03)

1.15 (0.83–1.58)

2.27 (1.61–3.31)

1.33 (1.04–1.70)

108

1.14 (0.82–1.59)

1.01 (0.75–1.37)

1.87 (1.34–2.60)

1.13 (0.90–1.41)

81

1.16 (0.84–1.60)

1.08 (0.81–1.44)

1.95 (1.42–2.69)

1.18 (0.95–1.47)

54

1.19 (0.87–1.62)

1.01 (0.76–1.34)

1.95 (1.44–2.65)

1.17 (0.94–1.44)

27

1.20 (0.89–1.63)

1.07 (0.82–1.40)

1.92 (1.42–2.58)

1.21 (0.99–1.49)